	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	C 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	R 2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	C 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	R 2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	353.74	382.30	416.18	482.93	518.87	527.81	577.55	627.88	645.77	476.06	599.24	725.11	752.79	801.49	857.28	888.41
Cost of Operating Revenue	188.60	192.36	197.96	225.97	237.11	256.03	257.80	278.88	276.06	224.60	299.60	363.13	353.60	380.15	414.99	424.57
Gross Profit	165.15	189.94	218.22	256.95	281.75	271.77	319.74	349.00	369.71	251.45	299.64	361.98	399.19	421.34	442.29	463.84
Gross Margin	46.7	49.7	52.4	53.2	54.3	51.5	55.4	55.6	57.3	52.8	50.0	49.9	53.0	52.6	51.6	52.2
Total Operating Expenses	332.29	364.62	399.34	459.00	485.56	501.24	550.13	592.93	631.80	469.64	589.97	706.43	728.37	774.97	839.86	858.89
Operating Profit	21.45	17.68	16.84	23.93	33.31	26.56	27.42	34.95	13.97	6.42	9.27	18.68	24.42	26.53	17.42	29.52
Operating Margin	6.1	4.6	4.0	5.0	6.4	5.0	4.7	5.6	2.2	1.3	1.5	2.6	3.2	3.3	2.0	3.3
Financing Income/(Expense) - Net	2.03	4.18	3.07	2.90	2.22	2.32	2.65	4.33	5.22	8.20	11.83	41.69	59.72	66.40	67.51	-2.69
Profit before Taxes	23.55	21.62	19.67	26.33	35.53	29.18	30.15	39.26	19.42	22.62	24.84	61.64	84.12	108.33	82.56	93.77
Income Taxes	7.92	7.42	7.28	10.18	12.86	10.44	11.98	14.89	7.11	-14.16	6.33	16.97	21.28	26.67	16.88	19.81
Profit after Tax	15.63	14.20	12.39	16.16	22.67	18.74	18.17	24.37	12.32	46.44	41.59	639.71	62.84	81.66	65.68	73.96
PAT Margin	4.4	3.7	3.0	3.3	4.4	3.6	3.1	3.9	1.9	9.8	6.9	88.2	8.3	10.2	7.7	8.3
EPS - Basic - ex Extraordinary Items	20.13	18.29	15.95	20.80	29.19	24.13	12.86	17.25	8.72	26.03	13.10	31.61	44.47	57.79	46.48	52.34
EPS - Diluted - ex Extraordinary Items	20.13	18.29	15.95	20.80	29.19	24.13	12.86	17.25	8.72	26.03	13.10	31.61	44.47	57.79	46.48	52.34
EBIT	21.45	17.68	16.84	23.93	33.31	26.56	27.42	34.95	13.97	6.42	9.27	18.68	24.42	26.53	17.42	29.52
EBITDA	24.13	20.57	20.01	30.07	40.51	38.48	42.66	49.62	28.35	20.13	22.46	31.49	37.48	34.86	26.18	38.24
EBITDA Margin	6.8	5.4	4.8	6.2	7.8	7.3	7.4	7.9	4.4	4.2	3.7	4.3	5.0	4.3	3.1	4.3

Balance Sheet

Abridged

Understanding Balance Sheet

TTK Healthcare Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	R 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31
	R 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	146	154	163	166	174	167	256	272	298	375	449	1,066	1,077	1,104	1,218
Long-Term Investments	-	-	-	-	7	9	9	13	9	13	15	14	36	78	19
Property Plant & Equipment - Net	39	43	55	97	107	99	110	99	97	86	80	74	76	81	74
Total Non-Current Assets	46	55	77	109	125	118	152	144	134	119	110	104	129	177	111
Total Assets	192	209	240	275	300	285	407	416	431	494	559	1,170	1,206	1,281	1,329
Total Current Liabilities	94	100	106	129	152	120	168	157	172	189	221	211	202	211	206
Long Term Debt	0	1	16	16	1	1	1	0	1	1	1	1	1	2	2
Total Non-Current Liabilities	10	11	27	28	6	8	7	7	11	11	8	6	4	5	8
Total Liabilities	105	111	133	157	158	127	174	164	182	200	229	217	205	216	214
Total Shareholders' Equity	88	98	107	118	141	157	233	251	249	295	330	953	1,001	1,065	1,115
Total Equity	88	98	107	118	141	157	233	251	249	295	330	953	1,001	1,065	1,115
Total Liabilities & Equity	192	209	240	275	300	285	407	416	431	494	559	1,170	1,206	1,281	1,329

Cash Flow

Abridged

Understanding Cash Flow Statement

TTK Healthcare Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	C 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	C 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	11.47	15.65	19.08	20.46	30.56	31.99	35.31	40.17	20.85	71.05	58.73	-135.53	64.69	63.71	76.26
Working Capital - Increase/(Decrease)	-7.62	6.29	-9.26	15.50	3.58	-12.75	-7.35	-18.77	4.03	41.19	-3.84	-45.16	-15.33	-3.12	-32.63
Net CF from Operating Activities	3.86	21.94	9.83	35.96	34.15	19.24	27.96	21.40	24.87	112.23	54.89	-180.69	49.36	60.58	43.64
Capital Expenditures - Net	4.29	7.52	15.40	49.17	16.76	5.39	4.27	4.31	11.54	1.67	2.92	11.44	10.26	-10.46	3.59
Net CF from Investing Activities	-4.29	-0.55	-14.63	-49.17	-26.76	0.71	-29.95	2.18	-21.60	-95.28	-43.43	184.68	-28.95	-45.22	-16.04
Dividends Paid - Cash - Total	3.61	3.61	3.63	3.63	4.21	4.66	4.67	8.52	8.52	4.24	8.48	14.13	14.13	14.13	14.13
Debt - LT & ST - Issuance/(Retirement) - Total	5.14	4.01	8.69	10.06	-3.35	-15.16	2.20	-18.83	1.62	-10.69	2.33	4.60	-4.64	-3.19	-0.59
Net Cash Flow from Financing Activities	1.53	0.40	5.05	6.43	-7.55	-19.82	-2.47	-27.35	-6.90	-14.93	-6.15	-9.53	-18.77	-17.32	-14.72
Free Cash Flow to Equity	4.71	18.42	3.12	-3.15	14.04	-1.31	25.90	-1.74	14.96	99.87	54.29	-187.53	34.46	67.85	39.45
Free Operating CF net dividend	-4.15	10.67	-9.25	-16.89	13.10	9.17	18.86	8.55	4.12	106.26	40.91	-206.52	24.85	33.61	23.71
Free Operating CF	-0.54	14.28	-5.62	-13.25	17.31	13.83	23.53	17.07	12.64	110.50	49.39	-192.39	38.98	47.74	37.84

Business Segment Analysis

FY End:

Mar 26

TTK Healthcare Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Revenue / Sales

Consumer Products (28.1%)₹ 241.28 CrProtective Devices (25.3%)₹ 216.51 CrFoods (17.6%)₹ 151.10 CrAnimal Welfare (16.5%)₹ 141.08 CrMedical Devices (12.5%)₹ 106.92 CrOthers (0.0%)₹ 0.39 Cr

Regional Segment Analysis

FY End:

Mar 26

TTK Healthcare Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (93.6%)₹ 802.35 CrOutside India (6.4%)₹ 54.93 Cr

Historical Segment Analysis

Track how TTK Healthcare Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Sales

Assets

Business

Regional

Business

We don't have enough data to show the Capex for TTK Healthcare Ltd..

Frequently Asked Questions

What is the revenue of TTK Healthcare Ltd.?

The latest trailing twelve month revenue of TTK Healthcare Ltd. is ₹ 888.41 Cr, reflecting a 1-year growth of 8.34% and a 3-year CAGR of 6.54%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of TTK Healthcare Ltd.?

The latest trailing twelve month net profit (PAT) of TTK Healthcare Ltd. is ₹ 73.96 Cr, with a 3-year earnings CAGR of 13.72%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of TTK Healthcare Ltd.?

The trailing twelve month EBITDA of TTK Healthcare Ltd. is approximately ₹ 29.52 Cr (based on an operating margin of 3.32%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of TTK Healthcare Ltd.?

The trailing twelve month Earnings Per Share (EPS) of TTK Healthcare Ltd. is 46.48. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of TTK Healthcare Ltd.?

The debt-to-equity ratio of TTK Healthcare Ltd. stands at 0.02. The interest coverage ratio is 10.97x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of TTK Healthcare Ltd.?

The estimated book value per share of TTK Healthcare Ltd. is 788.99 (derived from a P/B ratio of 1.41 and market price of ₹ 1,112.60), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of TTK Healthcare Ltd.?

The trailing twelve month operating cash flow of TTK Healthcare Ltd. is ₹ 43.64 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does TTK Healthcare Ltd. report consolidated or standalone financials?

TTK Healthcare Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.